MOU has not yet signed, take-off headed nowhere, which means bacically BRM needs the BIG Japanese boy to help them to take-off, as Chinese investors were not keen in BRM!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%